Healthcare provider profile · identity verified

Vincent B Proy, MD

Family Practice · CORRY, PA · NPI 1023270741

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	662	169
Atorvastatin Calcium	Atorvastatin Calcium	571	156
Lisinopril	Lisinopril	550	140
Levothyroxine Sodium	Levothyroxine Sodium	478	101
Amlodipine Besylate	Amlodipine Besylate	469	125
Metoprolol Succinate	Metoprolol Succinate	394	107
Losartan Potassium	Losartan Potassium	362	97
Duloxetine Hcl	Duloxetine Hcl	333	66
Pantoprazole Sodium	Pantoprazole Sodium	324	82
Ozempic	Semaglutide	301	50
Metformin Hcl Er	Metformin Hcl	282	75
Tamsulosin Hcl	Tamsulosin Hcl	268	65
Omeprazole	Omeprazole	255	73
Famotidine	Famotidine	226	75
Potassium Chloride	Potassium Chloride	214	41
Hydrochlorothiazide	Hydrochlorothiazide	204	52
Gabapentin	Gabapentin	203	58
Eliquis	Apixaban	194	43
Pravastatin Sodium	Pravastatin Sodium	192	53
Albuterol Sulfate Hfa	Albuterol Sulfate	175	54
Furosemide	Furosemide	156	40
Trazodone Hcl	Trazodone Hcl	153	36
Sertraline Hcl	Sertraline Hcl	151	34
Trulicity	Dulaglutide	151	27
Metoprolol Tartrate	Metoprolol Tartrate	145	35
Hydralazine Hcl	Hydralazine Hcl	143	34
Ezetimibe	Ezetimibe	141	38
Jardiance	Empagliflozin	134	43
Montelukast Sodium	Montelukast Sodium	124	25
Fluticasone Propionate	Fluticasone Propionate	122	51
Aripiprazole	Aripiprazole	121	17
Allopurinol	Allopurinol	104	20
Alendronate Sodium	Alendronate Sodium	103	38
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	103	32
Pregabalin	Pregabalin	102	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	97	22
Rybelsus	Semaglutide	97	24
Bumetanide	Bumetanide	94	21
Citalopram Hbr	Citalopram Hydrobromide	93	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	24
Carvedilol	Carvedilol	86	26
Simvastatin	Simvastatin	84	21
Baclofen	Baclofen	81	26
Celecoxib	Celecoxib	78	28
Clonidine Hcl	Clonidine Hcl	77	14
Metformin Hcl	Metformin Hcl	76	23
Cephalexin	Cephalexin	74	24
Buspirone Hcl	Buspirone Hcl	73	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	73	16
Escitalopram Oxalate	Escitalopram Oxalate	71	20
Spironolactone	Spironolactone	69	18
Primidone	Primidone	68	18
Farxiga	Dapagliflozin Propanediol	64	14
Glipizide Er	Glipizide	64	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	64	12
Myrbetriq	Mirabegron	63	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	63	16
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	63	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	63	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	62	14
Dutasteride	Dutasteride	61	13
Fluoxetine Hcl	Fluoxetine Hcl	60	16
Atenolol	Atenolol	57	17
Xarelto	Rivaroxaban	55	suppressed
Clopidogrel	Clopidogrel Bisulfate	53	13
Ipratropium Bromide	Ipratropium Bromide	50	19
Meloxicam	Meloxicam	46	13
Lorazepam	Lorazepam	44	13
Memantine Hcl	Memantine Hcl	44	14
Bupropion Xl	Bupropion Hcl	43	15
Tradjenta	Linagliptin	42	suppressed
Mounjaro	Tirzepatide	39	12
Carbidopa-Levodopa Er	Carbidopa/Levodopa	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Oxybutynin Chloride Er	Oxybutynin Chloride	35	12
Donepezil Hcl	Donepezil Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	32
Naproxen	Naproxen	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Testosterone Cypionate	Testosterone Cypionate	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Prednisone	Prednisone	33	19
Alfuzosin Hcl Er	Alfuzosin Hcl	32	11
Chlorthalidone	Chlorthalidone	31	suppressed
Gemtesa	Vibegron	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	11
Levetiracetam	Levetiracetam	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Azithromycin	Azithromycin	29	22
Colchicine	Colchicine	29	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	suppressed
Repatha Sureclick	Evolocumab	28	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Finasteride	Finasteride	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Nurtec Odt	Rimegepant Sulfate	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Valsartan	Valsartan	22	suppressed
Mometasone Furoate	Mometasone Furoate	21	suppressed
Prolia	Denosumab	21	13
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Scopolamine	Scopolamine	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Klor-Con M20	Potassium Chloride	18	suppressed
Methylprednisolone	Methylprednisolone	18	18
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Elmiron	Pentosan Polysulfate Sodium	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Invokana	Canagliflozin	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Torsemide	Torsemide	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Olanzapine	Olanzapine	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Praluent Pen	Alirocumab	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Linzess	Linaclotide	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error